Free Trial

Belite Bio (BLTE) SEC Filings & 10K Form

Belite Bio logo
$66.61
+6.06 (+10.01%)
(As of 10/31/2024 ET)

Recent Belite Bio SEC Filings

DateFilerForm TypeView
10/08/2024
4:46 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144/A
10/08/2024
4:48 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144/A
10/03/2024
7:48 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:50 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
5:03 AM
Belite Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/20/2024
11:40 AM
Belite Bio (Subject)
Liaw Wei-Cheng (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
11:29 AM
Belite Bio (Subject)
Chen Wan-Shan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:24 PM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
1:38 PM
Belite Bio (Subject)
Chiu Ching Chen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:30 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
2:17 PM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
3:45 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
3:47 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
10:36 AM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
1:23 PM
Belite Bio (Subject)
Chiu Ching Chen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
8:57 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
12:37 PM
Belite Bio (Filer)
Form 424B5
04/25/2024
8:02 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:26 AM
Belite Bio (Subject)
Chen Wan-Shan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
2:58 PM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
7:51 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:05 PM
Belite Bio (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/11/2024
8:59 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
8:08 PM
Belite Bio (Subject)
Lin Yu-Hsin (Filed by)
Form SC 13G
02/12/2024
7:40 PM
Belite Bio (Subject)
Lin Bioscience International Ltd. (Filed by)
Form SC 13G
12/28/2023
3:15 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
3:16 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:36 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:41 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BLTE) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners